KPLBSEKwality Pharmaceuticals LtdMediumNeutral
Announced Tue, 2 Jun · 17:23 IST

Appointment of Mr. Swanith Kapoor as Additional (Non-Executive, Independent) Director and Resignation of Mr. Kartik Kapur, Independent Director of the Company.

Management Changes View source PDF

KPL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹2324.90
prior close
₹2333.30
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.1+0.0-0.6+2.4+2.6-2.4+0.7+7.4+7.1+5.7+15.1
Up moveDown movePending
AI summary

Kwality Pharmaceuticals has appointed Mr. Swanith Kapoor (DIN: 11662482) as an Additional (Non-Executive, Independent) Director for a 5-year term from June 2, 2026 to June 1, 2031, subject to shareholder approval. Mr. Kapoor is a legal professional with a B.B.A. LL.B. (Hons.) specializing in Corporate Law and is pursuing a Master's in Business Laws from NLSIU, Bengaluru. Separately, Mr. Kartik Kapur (DIN: 08966816) has resigned as Independent Director effective close of business hours on June 2, 2026, citing other professional commitments. Mr. Kapur confirmed there are no other material reasons for his resignation and does not hold directorships in any other listed company. The Managing Director, Mr. Ramesh Kumar, has signed the disclosure filing under SEBI Listing Regulations.

Likely market impact

This is a routine board reshuffle with one independent director replacing another; net impact on board composition is neutral, and shareholders will need to approve the new appointment at the next general meeting.